Literature DB >> 28314897

Transient osteoporosis of the hip: review of the literature.

K Asadipooya1,2, L Graves3, L W Greene4,5.   

Abstract

Transient osteoporosis of the hip (TOH) is a temporary clinical condition of unknown etiology which usually resolves with conservative therapy though may be complicated by fracture or progression to avascular necrosis (AVN). TOH may be slightly more prevalent in men but when it occurs in women, it is most often seen in the latter part of pregnancy. Though fracture is a rare complication of TOH when it occurs, it is most often associated with TOH occurring in pregnancy. Magnetic resonance imaging (MRI) is the best method to diagnosis TOH. Low signal intensity on T1-weighted images, high signal intensity on T2-weighted images, and homogenous pattern of edema (the femoral head and/or neck) with normal subchondral area are in favor of TOH. A shortened course to recovery is reported by use of bisphosphonates, calcitonin, or teriparatide. Based on reported cases, core decompression is not superior to medical therapy. Transient osteoporosis of the hip, which often has no known etiology, usually resolves with conservative therapy but may predispose the patient to fracture or avascular necrosis. Diagnostic method of choice is magnetic resonance imaging. Bisphosphonates, calcitonin, or teriparatide are reported as a useful approach to reduce duration of recovery.

Entities:  

Keywords:  Bone marrow edema; Transient osteoporosis

Mesh:

Substances:

Year:  2017        PMID: 28314897     DOI: 10.1007/s00198-017-3952-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  104 in total

1.  Transient bone marrow edema syndrome progressing to avascular necrosis of the hip - a case report and review of the literature.

Authors:  S Radke; W Kenn; J Eulert
Journal:  Clin Rheumatol       Date:  2003-12-19       Impact factor: 2.980

2.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

Review 3.  Primary hyperparathyroidism during pregnancy.

Authors:  Vincent Dochez; Guillaume Ducarme
Journal:  Arch Gynecol Obstet       Date:  2014-11-04       Impact factor: 2.344

4.  Fracture complicating the bone marrow edema syndrome.

Authors:  Sherry A Guardiano; James Katz; Arnold M Schwartz; Kathleen Brindle; Rudolfo Curiel
Journal:  J Clin Rheumatol       Date:  2004-10       Impact factor: 3.517

5.  Successful operative treatment of a displaced subcapital fracture of the hip in transient osteoporosis of pregnancy. A case report and review of the literature.

Authors:  R J Fingeroth
Journal:  J Bone Joint Surg Am       Date:  1995-01       Impact factor: 5.284

Review 6.  Calcitonin in the treatment of transient osteoporosis of the hip.

Authors:  Thurayya K Arayssi; Hussein A Tawbi; Ihab M Usta; Mukbil H Hourani
Journal:  Semin Arthritis Rheum       Date:  2003-06       Impact factor: 5.532

7.  Regional migratory osteoporosis: case report of a patient with neuropathic pain.

Authors:  Esin Kartal; Ebru Sahin; Banu Dilek; Meltem Baydar; Metin Manisali; Can Kosay; Selmin Gulbahar
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

8.  Idiopathic transient osteoporosis of the hip.

Authors:  L Z Shifrin; N D Reis; H Zinman; M I Besser
Journal:  J Bone Joint Surg Br       Date:  1987-11

9.  Distinguishing transient osteoporosis of the hip from avascular necrosis.

Authors:  Anita Balakrishnan; Emil H Schemitsch; Dawn Pearce; Michael D McKee
Journal:  Can J Surg       Date:  2003-06       Impact factor: 2.089

10.  [Bilateral fracture of the femoral neck following transient osteoporosis in pregnancy].

Authors:  R Münker; C Niedhart; F U Niethard; B Schmidt-Rohlfing
Journal:  Z Orthop Ihre Grenzgeb       Date:  2007 Jan-Feb
View more
  22 in total

1.  Zoledronic acid in nine patients with transient osteoporosis of the hip.

Authors:  Gerasimos Evangelatos; George E Fragoulis; Alexios Iliopoulos
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

2.  Transient osteoporosis: an unusual presentation of hip pain in a trail runner.

Authors:  Volker Scheer
Journal:  BMJ Case Rep       Date:  2019-07-10

3.  A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.

Authors:  M Varenna; C Crotti; M T Bonati; F Zucchi; M Gallazzi; R Caporali
Journal:  Osteoporos Int       Date:  2021-08-31       Impact factor: 4.507

4.  A case of regional migratory osteoporosis.

Authors:  J Spierings; S Bours; H R M Peeters
Journal:  Osteoporos Int       Date:  2017-10-24       Impact factor: 4.507

5.  Zoledronic acid for the treatment of pregnancy-associated femoral head necrosis: A case report.

Authors:  Estella Musacchio; Leonardo Sartori
Journal:  Case Rep Womens Health       Date:  2020-03-19

6.  Short-Term Teriparatide for Bone Marrow Edema Secondary to Complex Regional Pain Syndrome: Case Reports on Efficacy After Two Years of Follow-Up.

Authors:  Felice Galluccio; Abdallah El Sayed Allam; Francesco Perdisa; Ke-Vin Chang
Journal:  Cureus       Date:  2020-05-14

7.  Transient Osteoporosis of the Hip: Risk and Therapy.

Authors:  Khaldoon M Bashaireh; Fa'ek M Aldarwish; Ali A Al-Omari; Moath A Albashaireh; Mai Hajjat; Mohammad A Al-Ebbini; Abdelwahab J Aleshawi
Journal:  Open Access Rheumatol       Date:  2020-01-09

8.  Atraumatic Displaced Femoral Neck Fracture Postpartum: A Case Report and Review of the Literature.

Authors:  Samantha Tayne; David Fralinger; Arif Ali
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2019-09-17

9.  Extracorporeal shock wave therapy for bone marrow edema syndrome in patients with osteonecrosis of the femoral head: a retrospective cohort study.

Authors:  Wenyi Zhao; Yuan Gao; Shouxiang Zhang; Zhang Liu; Lin He; Dahong Zhang; Wei Li; Qinggang Meng
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

10.  Neridronate for transient osteoporosis of the hip in a child.

Authors:  C Gaggiano; M Bardelli; M Tarsia; S Gentileschi; A Maselli; S Grosso; L Cantarini; B Frediani
Journal:  Osteoporos Int       Date:  2022-02-01       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.